The type A syndrome of insulin resistance and acanthosis nigricans is characterized by severe insulin resistance due to a cellular defect in insulin action. To better understand the molecular nature of this defect, we have investigated insulin binding to circulating monocytes, erythrocytes, and the Triton X-100-solubilized erythrocyte receptor, and insulin-stimulated receptor autophosphorylation using cells and receptor from three type A patients. Insulin binding in both circulating cells and the soluble extract of erythrocytes indicated a heterogeneity of defects. Patients A 1 and A 2 both presented a major decrease in tracer insulin binding to intact cells and soluble insulin receptor. Determination of stoichiometric binding parameters using a cooperative model indicated that in patient A 1 this was due to a reduction in the number of receptors, whereas in patient A 2 the affinity constant for binding was decreased. Patient A 3 presented near-normal insulin binding to erythrocytes and normal binding in intact monocytes, solubilized erythrocyte receptors, and cultured fibroblasts. Affinity labeling of erythrocyte receptor from this patient revealed a normal a-subunit and also a normal relative distribution of the higher-molecularweight, nonreduced oligomeric forms of the receptor.
These data and the correlation of coupling of receptor phosphorylation with the fractional occupancy of the receptor measured in the same extract suggest that these patients exhibit three types of defects. In patient A,, there is a loss in receptor number manifested by a parallel decrease in insulin binding and receptor phosphorylation. In patient A 2 , there is an additional decrease in the affinity constant leading to a decrease in both binding and receptor phosphorylation with an almost linear coupling between receptor occupancy and receptor phosphorylation. Patient A 3 , on the other hand, appears to have a specific defect located at the level of the p-subunit of the insulin receptor leading to a decrease in phosphorylation despite normal insulin binding. Thus, the type A syndrome of insulin resistance is characterized by a major impairment in receptor autophosphorylation, despite heterogeneous insulin binding defects. The defects appear to be expressed on circulating erythrocytes, suggesting that these cells are a suitable cellular model for study of the insulin receptor in diabetic States. DIABETES 1986; 35:127-38.
M
any diabetic syndromes are associated with a decrease in cellular response to circulating insulin, i.e., insulin resistance. The most striking of these is the type A syndrome of insulin resistance and acanthosis nigricans in which circulating insulin concentrations 100-1000 times the normal level are necessary to produce a significant effect on glucose homeostasis. 1 This syndrome appears in young females together with polycystic ovarian disease, signs of virilization, acanthosis nigricans, and accelerated growth. Based on studies of insulin binding to specific membrane receptors of various cells obtained from patients with this syndrome, previous workers suggested that a major loss of the number of insulin receptors was the primary defect in at least some of these patients. 24 However, the contribution of the insulin-binding defect to the insulin resistance, as well as the molecular nature of this defect, are not completely understood, since some patients with type A phenotype have normal insulin binding. We and others have shown that the insulin receptor, like the receptors for epidermal growth factor 7 and platelet-derived growth factor, 8 is a hormone-stimulated, tyrosine-specific protein kinase. 9 17 Both the binding and kinase activity appear to be intrinsic to the receptor and are contained in two distinct subunits. Insulin binds to the a-subunit and stimulates the autophosphorylation of tyrosine residues of the (3-subunit of the receptor. The phosphorylation reaction is one of the earliest events that occurs upon binding of insulin (within seconds), suggesting that this reaction may be involved in signal transduction across the cellular membrane. 17 One approach to test this hypothesis is to study pathologic conditions characterized by severe insulin resistance and in which the defect, located at the receptor level, is primary. The type A syndrome offers such an opportunity. A suitable cellular model to study the binding and kinase properties of the receptor from these patients is the circulating erythrocyte. We have recently shown that sufficient quantities of solubilized receptor can be obtained from erythrocytes of a single individual to study binding and kinase properties in different pathologic states.' 8 Using this assay, we have shown a defect in receptor phosphorylation in a type A patient with normal insulin binding; 19 a similar finding has been reported by Grunberger et al. on circulating monocytes. 20 In the present study, we have investigated in more detail the binding and kinase properties of the soluble receptor of erythrocytes in our original case of type A syndrome (A 3 ), as well as in two additional type A patients (A, and A 2 ) who present defects in phosphorylation, as well as typical alterations in insulin receptor number or affinity.
MATERIALS AND METHODS
Patients. The patients, designated A,, A 2 , and A 3 Boston, were young females (15-21 -yr-old) who presented the association of insulin resistance with acanthosis nigricans, polycystic ovarian disease with signs of hirsutism, and elevated levels of testosterone. The insulin resistance was manifested by high levels of insulin both in the fasting state and after glucose stimulation as well as resistance to exogenous insulin. Some of the pertinent data are summarized in Table 1 . Patient A, had fasting hyperglycemia and overt diabetes. Patients A 2 and A 3 had normal fasting glucose levels but impaired glucose tolerance.
Experimental protocol. One hundred milliliters of blood was freshly drawn after an overnight fast into syringes containing 15 U/ml heparin (Eli Lilly and Company, Indianapolis, Indiana). No hematologic abnormalities were observed in these patients by routine laboratory methods: mean red cell volume was 86, 84, and 83 (xm 3 (control 90 ± 9 |xm 3 ), mean concentration of hemoglobin per cell (MCHC) was 35.8, 35.5, and 35.4 g/dl (control 33-37 g/dl), and the reticulocyte count was < 1 % for the patients A,, A 2 , and A 3 , respectively. Simultaneous controls (age-and sex-matched) were studied in each determination. For patient A 2 , the control was the unaffected sister. The mononuclear leukocytes were separated from erythrocytes by gradient centrifugation on Ficoll (9%)-Hypaque (33.9%) as described by Boyum et al. 21 The white cells were counted in a hemocytometer and the percent of mononuclear cells was obtained by the latex beads method. 22 The red blood cells were counted in an automatic Coulter counter (S790 Coulter Electronics, Inc., Hialeah, Florida). For both insulin binding to intact cells and binding and protein kinase assay in solubilized fractions, two suspensions of cells (control and the patient) containing the same number of erythrocytes (100 ml of 4.4 x 10 9 cells/ml) were prepared before the preparation of membranes and solubilization with Triton X-100. Insulin binding. Insulin binding was performed on monocytes as previously described 23 and for the intact erythrocytes by the method of Gambhir et al. ]monoiodoinsulin (360 |jiCi/|xg) was purified by high-performance liquid chromatography (HPLC) using the method of Markussen and Larsen, 25 as previously described. 18 Insulin binding to solubilized receptor of erythrocytes was performed using a crude Triton X-100 extract of an insideout membrane preparation.' 8 Solubilization of inside-out ghosts is essential for conserving all native binding properties of the insulin receptor. The orientation of the membranes was confirmed by phase-contrast microscopy and also by gel electrophoresis analysis of the erythrocyte cytoskeletal proteins remaining after the detergent extraction. Two simultaneous insulin binding assays were performed at 0.08% Triton and 0.150 ± 0.02 mg/ml protein (standard conditions) and at 0.8% Triton and 1.4-1.7 mg/ml protein (phosphorylation conditions). This second assay was performed to measure the actual hormone bound to solubilized receptors under the conditions used for the phosphorylation assay. Protein concentrations were determined by the dye-binding method (Bio-Rad, Richmond, California) using bovine serum albumin as standard. Affinity labeling of the erythrocyte insulin receptor.
125 Iinsulin was cross-linked to the erythrocyte insulin receptor by the method previously described.
26125 l-[Tyr A14 ]monoiodoinsulin (5 ng) was incubated in the presence or absence of unlabeled insulin (10,000 ng/ml) with a 2-ml suspension of erythrocytes (3.6 x 10 9 cell/ml) for 90 min at 15°C in the buffer used for binding studies. 18 The cells were then pelleted by centrifugation for 20 min at 400 x g and resuspended in the same buffer, but omitting bovine serum albumin, and in the presence of a 0.5-mM final concentration of disuccinimidyl suberate (freshly dissolved in dimethyl sulfoxide). The reaction was allowed to proceed for 15 min at 15°C and the cells were then washed three times with the same buffer S FLIER. AND C. R. KAHN without albumin. Inside-out, unsealed ghosts were prepared by hemolysis as previously described, 18 and the insulin receptors were extracted with 1% Triton X-100 as described above. Aliquots of the supernatant obtained after ultracentrifugation were submitted to SDS-PAGE (7.5% acrylamide) under nonreducing or reducing conditions (100 mM DTT). Insulin receptor autophosphorylation. The insulin receptor kinase assay was performed as previously described 18 using the detergent extract at high protein concentration (1.4-1.7 mg/ml protein). The extract was incubated with different concentrations of insulin (from 0 to 10,000 ng/ml) for 15 h at 4°C. Stoichiometric binding parameters were determined by a statistical curve-fitting procedure contained as an original subroutine (F. Grigorescu, R. C. Rodgers, and P. DeMeyts, manuscript in preparation) in the MLAB program. 28 The model functions of the stoichiometric cooperativity model of DeMeyts 29 were fitted directly on the competition curve (expressed as cpm) and also contained a parameter for the nonspecific binding. The nonspecific had values of 3.4%, 0.9%, and 5.6% for the intact erythrocytes and monocytes and solubilized fraction, respectively. K e and K, refer, to the affinity constants and are expressed as M~\ R o refers to binding capacity and is expressed as pmol/3.6 x 10 12 erythrocytes, in pmol/1 x 10 7 monocytes/ml for the assay performed in intact cells, and in pmol/mg protein for the solubilized receptor preparation. The 95% confidence limits were calculated by Eq. (1) The autophosphorylation of the (3-subunit of the insulin receptor was measured by scanning densitometry of the autoradiograms. The basal value (parameter A) of the control was considered equal to unity and the experimental data points were calculated as relative incorporation of phosphate to the basal level. The logistic parameters were obtained by a statistical curve fitting using a four-parameter logistic equation 32 as previously described. 18 The phosphorylation reaction was conducted in the presence of 4 mM MnCI 2 , 50 M-M cold ATP, and 100 puCi/tube P]ATP. After 10 min, the reaction was stopped by addition of cold "stopping solution" containing 50 mM NaF, 10 mM sodium pyrophosphate, 5 mM EDTA, and 5 mM ATP. The insulin receptor was then identified by specific imrmunoprecipitation with antireceptor antibody (serum B-8 at 1:50 dilution) and the immune complexes were precipitated with protein-A (Pansorbin, Calbiochem, La Jolla, California). The pellets were submitted to SDS gel electrophoresis under reducing conditions (100 mM dithiothreitol). 27 The phosphorylated (3-subunit of the insulin receptor was identified by autoradiography and quantitated by counting the bands corresponding to the p-subunit of the receptor in a scintillation counter or by scanning densitometry of the autoradiograms. Analysis of data. The insulin binding data were analyzed by a computer-assisted, statistical curve-fitting procedure contained as an original subroutine (F. Grigorescu, R. C. Rodgers, and P. DeMeyts, manuscript in preparation) in the MLAB program. 28 In the figures, insulin binding is displayed as competition-inhibition curves (bound-to-free ratio, B/F, versus total insulin concentration) of the patients and the simultaneous controls. A comparison of B/F values of the patients to the normal population can be obtained from the text, in which data are presented as mean and standard deviation.
Stoichiometric binding parameters for the insulin binding were obtained by fitting the model function directly to the competition curve expressed as counts per minute. Each model function also contains a parameter for the nonspecific binding and is expressed as percent of the total radioactivity added in the assay. Although two-sites, Hill-Sips, and negative cooperative models were tested, since there were no statistical criteria that favor one of the models, the data are presented using a stoichiometric cooperative model proposed by DeMeyts 29 to which most investigators are accustomed.
Within each model, the minimalization of the root mean square errors or final sum of squares were used as criteria for the goodness of the fit. This was also appreciated by the graphical analysis of residuals Table 2 ). The curves for the patients (O) and for the simultaneous control ( • ) are the best fit of a logistic equation. 32 fitting of the affinity constant (K) and binding capacity (R o ) are shown in 
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where M is the parameter value; t is the two-tailed 95th percentile value of Student's ^-distribution, and SEM is the standard error of the mean. Statistical analysis of the patients' values compared with controls was performed by constructing the 95% joint tolerance ellipse of log K e and log R o values. The semi-axes were calculated by:
Sy ± V ( S X + Sy) 2 -4(SxSy -S 2 xy) (2) where l 12 are the semi-axes of the ellipse, F is obtained from an F-distribution table with the appropriate degree of freedom, n is the number of determinations, S x and S y are the variance of log K e and log R o , respectively, and S xy is the covariance. 31 The orthogonal regression coefficients (b 0 and -1 /b 0 ) for the x and y axes were calculated by:
where S x , S y , and S xy are as in Eq. (2). This tolerance ellipse significantly exceeds the minimum area needed to encompass all of the normal data points, since it takes into account in the analysis the tolerance limits of two populations of interdependent values (see Figure 3) . Thus, when a joint point representing the log K e and log R o of a patient is situated outside this ellipse, we can predict with 95% certainty that one of the parameter's values is abnormal compared with controls. In the data on monocyte binding, we were able to compare several determinations with each of the patient's cells to the control group; thus, 95% confidence ellipses were constructed using similar procedures. 31 The statistical significance in this case is judged as a function of the degree of overlap of the two surfaces (see Figure 4) .
The dose-response curves for the phosphorylation assay were analyzed using a four-parameters logistic equation 32 as previously described. 18 The parameters were: A, the basal activity; B, the slope of the curve; C, the concentration of insulin necessary to obtain the half-maximal effect (ED 50 ); and D, the maximal stimulation of phosphate incorporation into the p-subunit of the insulin receptor. The basal activity and the maximal phosphorylation were expressed in arbitrary units obtained by scanning densitometry. To compare patients' values to the normal population, the phosphate incorporation was expressed as relative incorporation to basal level (Table 3 ). Statistical analysis of the values of the protein kinase assay was performed using Student's Mest. All steps of the interactive program were displayed on a 4006-1 Tektronix terminal.
RESULTS
Insulin binding to circulating erythrocytes and monocytes. Insulin binding to intact erythrocytes and monocytes obtained from the type A patients revealed a heterogeneity of defects. Erythrocytes for patient A, displayed a marked reduction in initial bound-to-free ratio (B/F = 0.016/3.6 x 10 9 cells/ml) when compared with a simultaneous control (Figure 1 , left) or to a group of controls (B/F = 0.115 ± 0.038 for normals, mean ± 1 SD, N = 10). The ED 50 was 3 ng/ml (control 2 ng/ml, range 1.8-10 ng/ml), suggesting that the remaining receptors had a normal affinity for insulin and the decrease in binding was due to a decrease in the binding capacity. Statistical curve fitting on these data indicated that the decrease in insulin binding was due to a 90% decrease in the total number of re_ceptors_ (Table 2) . A slight increase in the affinity constants K e and K f were also observed. Insulin binding to erythrocytes from patient A 2 displayed a similar defect in tracer binding with a B/F of 0.022, which represents 20% of the simultaneous control and the mean control value. The ED 50 was 16 ng/ml, eight times higher than the mean control value, indicating a change in the affinity constant ( Figure 1, center panel) . Quantitative analysis using the cooperative model indicated that the decrease in binding was primarily due to a reduction in affinity constants K e and K, with a slight increase in the apparent binding capacity ( Table 2 ). These changes in affinity were confirmed in a repeat competition curve performed with twice the cell concentration (7.2 x 10 9 cells/ml). Again, the ED 50 was markedly increased (30 ng/ml insulin) and the values of the K e markedly reduced (0.6 x 10 8 M" 1 ). Similar alterations in insulin binding were also observed in circulating monocytes obtained from this patient ( Figure 2 ). Insulin binding was decreased by 60% when compared with the simultaneous control (the normal sister) or by 46% when compared with all control values (B/F = 0.0627 ± 0.017, mean ± 1 SD, N = 9). Stoichiometric binding parameters indicated a decrease in both affinity constants K e and K, to 40% and 21% of control levels, respectively ( Table 2) .
As previously reported, 19 32 binding to circulating erythrocytes. The initial B/F was 0.04, which was about 50% of the simultaneous control (Figure 1 , right) and 34% of the mean control value. This slight reduction in insulin binding to intact cejjs appeared to be due to a reduction in affinity constant K e with a normal binding capacity (Table 2 ). This alteration was most likely due to factors related to the membrane environment rather than the receptor itself, because it was not further observed in the soluble form of the receptor (vide infra). Furthermore, insulin binding to circulating monocytes of this patient was virtually indistinguishable from the simultaneous control and the B/F values were situated in the lower range of normals (Figure 2) . Quantitative analysis of insulin binding to monocytes indicated a slight, but not statistically significant, reduction in the affinity constants (Table 2) .
To identify whether these alterations described in the type A patients were statistically significant as compared with a normal_population, the correlated values of the affinity constant (K e ) and binding capacity (R o ) were compared with the 95% tolerance ellipse of a group of 10 normal control subjects, as described in MATERIALS AND METHODS ( Figure 3A) . Althojjgh both affinity constants (K e of the empty receptor and K, of the filled receptor) are correlated with the binding capacity, only the values of K e were used in this analysis. Values of K, are submitted to much more variability due to the lower precision of estimates in this portion of the binding curve.
As shown in Table 2 , the stoichiometric binding parameters obtained by curve fitting indicated, in normal erythrocytes, a mean value of the binding capacity of 246 pmol/3.6 x 10 9 cells. This corresponds to 41 ± 1 0 sites/cell at the 95% confidence limits. As noted in MATERIALS AND METHODS, the 95% tolerance ellipse calculated for the joint values of R o and K e exceeds the area needed to encompass the range of all values ( Figure 3A) , since this takes into account not only the variation about the mean, but also the tolerance limits of two populations of values. The joint points of K e and R o of patients A, and A 2 were clearly situated outside this ellipse, indicating a statistically significant decrease in binding capacity or affinity constant, respectively. By contrast, the jojnt point for patient A 3 , although exhibiting a lower affinity K e than any normal, was situated at the edge of this ellipse and, therefore, was of uncertain significance.
Similar conclusions were drawn when the same type of statistical analysis was performed on insulin binding to monocytes. In normal monocytes, the affinity constant K e was reduced compared with circulating red blood cells, since the experiments were performed at 20°C. The binding capacity of 749 pmol/10 7 cells/ml corresponds to 38,000 sites/cell with 95% confidence limits between 38,000 and 53,000 sites/ Figure 4 , the 95% confidence ellipse calculated for patient A 2 does not overlap the 95% confidence ellipse of controls, suggesting a significant decrease in affinity constant K e . By contrast, the 95% confidence ellipse calculated for patient A 3 overlaps all control values and the mean of patient's values is situated at the edge of normal confidence limits and, therefore, is of uncertain significance. Insulin binding to the solubilized insulin receptor of erythrocytes. When extracted with Triton X-100 from the erythrocyte membrane, the soluble insulin receptor retains all native binding properties demonstrated in intact cells or in other cellular systems, including insulin analogue specificity, immunologic recognition by antireceptor antibodies, and negative cooperative interactions, i.e., curvilinear Scatchard plots. However, the affinity constants K c and K, vary in function of the detergent concentration, being higher at low detergent concentration and vice versa. For this reason, in our original method 18 insulin binding was performed under two different conditions: one at 0.08% Triton X-100 and protein concentration of 0.14-0.17 mg/ml (standard conditions) and the other at 0.8% Triton X-100 and protein concentration of 1.4-1.7 mg/ml (phosphorylation conditions). In the present study, this last method was standardized, since these are the same conditions used in the protein kinase assay. With the receptors extracted from control erythrocytes, the insulin binding showed a competition-inhibition curve with the initial B/F of 0.094 ± 0.026 (mean ± 1 SD, N = 12) per milligram protein. The ED 50 was 3 ng/ml insulin. Binding parameters had a lesser variability than in the assay with intact cells and are shown in Table 2 . The affinity constant (K c ) was decreased fivefold compared with intact cells and 15-fold when compared with the low Triton conditions (K e = 1.73 x 10 9 M-1 ). 18 After solubilization with 0.8% Triton X-100, erythrocyte receptors from patient A, displayed a competition curve with initial B/F = 0.042 (expressed per milligram protein) with the ED 50 of 5.5 ng/ml. The value at tracer concentrations represents 40% of the mean control value and 36% of the simultaneous control ( Figure 5, left) . When the insulin binding was performed under standard conditions, i.e., 0.08% Triton, the initial B/F was even lower, being only 20% of the control value ( Figure 6 ). Stoichiometric binding parameters calculated for patient A, indicated a decrease in binding capacity by 64% with no modification in the affinity constants (Table  2) . These data are consistent with findings in circulating erythrocytes and suggest that the major modification in this patient was a decrease in total number of receptors.
cell (Table 2). As indicated in
The soluble insulin receptor of erythrocytes from patient A 2 also mirrored the modifications observed in intact cells. At 0.8% Triton, the initial B/F was 0.023, which represents 25% of the mean control value. The ED 50 was 70 ng/ml, 20 times higher than the control value ( Figure 5, center panel) . Statistical curve-fitting analysis revealed that the binding defect was due to a reduction in the affinity constant K e , although a decrease in binding capacity by 27% was also observed when compared with the mean control value (Table 2) .
When the receptor was extracted from the erythrocyte membranes of patient A 3 , the insulin binding performed in the solubilized fraction at 0.8% Triton X-100 was indistinguishable from the simultaneous control. The initial B/F was 0.064 or 69% of mean control value and 133% of the simultaneous control. The ED 50 was 0.4 ng/ml insulin ( Figure 5 , right). The same conclusion resulted when the insulin binding was performed in 0.08% Triton (Figure 6 ). Compared with all normal values, the binding capacity was slightly decreased but with a normal affinity constant ( Table 2) .
As with the measurements in intact cells, the statistical analysis of binding parameters for the soluble erythrocyte receptor was performed by constructing the 95%Jolerance ellipse of the correlated values of log R o and log K e ( Figure  3B ). For patients A, and A 2 , these values were situated outside the ellipse, confirming the alterations in the binding ca-pacity for patient A^ and in the affinity constant for patient A 2 . The joint point for patient A 3 , on the other hand, was situated inside this ellipse and within the cluster of normal values. Structure of the erythrocyte insulin receptor of patient A 3 . The structure of the insulin receptor in normal erythrocytes and patient A 3 was examined by affinity labeling with 1 2 5 Iinsulin and SDS-PAGE under reducing and nonreducing conditions (Figure 7) . Under reducing conditions, the 125 l-insulin labeled a single band of M r = 135,000 consistent with the a-subunit of the receptor. 26 The insulin receptor of erythrocytes from patient A 3 revealed an a-subunit of the same apparent molecular weight when analyzed by SDS-PAGE (Figure 7, upper panel, lane B) . Under nonreducing conditions (in the absence of DTT), the autoradiograms of the gels for patient A 3 and the control revealed several oligomeric forms of the insulin receptor with molecular weights of >350,000 (a 2 p 2 or a n p m ), 270,000 (a 2 ), 210,000 (a(3), as well as a free a-subunit of M r = 135,000 daltons ( Figure 7, upper panel,  lanes A and B) . Scanning densitometry of these autoradiograms ( Figure 7 , lower panel) indicated no difference between patient A 3 and the control in the relative distribution of the oligomeric forms, with approximately 64% as a 2 (3 2 , 12-16% as a 2 , 4-7% as a(3, and 11% free a-forms. Affinity labeling of erythrocytes from patients A : and A 2 was not possible due to the low level of insulin binding. Insulin-stimulated receptor autophosphorylation. Autophosphorylation of the insulin receptor from the three type A patients was studied using the Triton-extracted erythrocyte receptor. Autoradiograms of the gels of receptor phosphorylation using receptor extracted from the type A patients and their simultaneous controls are shown in Figure 8 . Insulin stimulated the incorporation of phosphate into only one major band that was precipitated by antibody to insulin receptor. This phosphoprotein had a M r = 95,000 consistent with that of the p-subunit of the insulin receptor. Another minor protein of M r = 220,000 also appeared to be phosphorylated, but not in an insulin-dependent manner. This protein most likely represents the (3-chain of spectrin (band 2), the major cytoskeleton component of erythrocyte membrane that may have co-precipitated with the insulin receptor and that contains an intrinsic kinase activity.
Insulin stimulated the phosphorylation of the solubilized receptor preparation from normal subjects 4-7-fold above the basal level with a mean value of 5.7 ± 1.26 (mean ± 1 SD, N = 6, Figures 9 and 10) . Quantitation by scanning densitometry of autoradiograms of control subjects revealed a sig-' modial dose-response curve, with the ED 50 between 10 and 20 ng/ml insulin and with a slope factor 0.5-0.7. Some stimulation was observed with concentrations of insulin as low as 1 ng/ml, and maximal stimulation was obtained with a concentration of 5000-10,000 ng/ml insulin. 18 Scanning densitometry of the autoradiograms revealed a major decrease in the phosphate incorporation into the receptor in each of these patients when compared with their simultaneous controls ( Figure 9 ). The incorporation of phosphate at maximal insulin concentration was decreased by 79%, 76%, and 52% from the values of simultaneous controls of patients A,, A 2 , and A 3 , respectively. The ED 50 values were 59, 217, and 44 for patients A,, A 2 , and A 3 , respectively.
To determine whether the phosphorylation defect in these patients was statistically significant when compared with all controls (N = 6), the extent of phosphate incorporation was calculated relative to the basal level. The basal level of the simultaneous control was considered equal to unity (parameter A = 1) and a curve fitting using a logistic equation 32 was then performed on these values. The best-fitting values are presented in Table 3 and Figure 10 .
In patient A^ a 71% decrease in autophosphorylation was observed at both the basal and the maximally stimulated level value situated outside 1 SD and outside the normal range. This is consistent with the major decrease in receptor number observed in the insulin binding study with intact cells or solubilized receptor preparation. The ED 50 for insulin-stimulated phosphorylation was 59 ng/ml, suggesting that the remaining receptors were normally activated.
The extract from patient A 2 also exhibited an 82% decrease in maximal phosphate incorporation. In addition, a rightward shift of the dose-response curve was observed with an ED 50 of 206 ng/ml, consistent with the additional alteration in the affinity constant of the empty receptor (K e ) observed in the insulin binding study.
Interestingly, the extract from patient A 3 also presented a 40% decrease in the maximal phosphate incorporation into the receptor despite normal binding in the solubilized fraction. In contrast with other patients, this occurred with only a minor change in basal level of phosphorylation. The ED 50 was 19.4 ng/ml, a value that is within the normal range. Taken as a group, these patients presented a defect in maximal insulin- stimulated phosphorylation statistically significant from the mean value in control subjects (P < 0.005). Correlation between insulin-stimulated phosphorylation and fractional occupancy of the receptor. To better define the defect in these insulin-resistant patients, the phosphorylation of the insulin receptor was compared directly with the insulin binding data obtained in the solubilized fraction. A coupling plot, obtained as shown in Figure 11 , in which the relative incorporation of phosphate at each insulin concentration is plotted against the fractional occupancy of the receptor, gives an estimation of how the kinase is activated as a function of the actual hormone bound. With patients A, and A 3 , 32 P incorporation into the (3-subunit expressed as a function of fractional occupancy was similar to that in controls. Under the conditions used, 50% of maximal phosphorylation occurred at 10% receptor occupancy ( Figure 11 ). Thus, although both patients A^ and A 3 exhibited a decrease in basal and maximally stimulated phosphorylation, the remaining receptor phosphorylation exhibited a normal coupling to insulin binding and was indistinguishable from controls. In contrast, with patient A 2 ( Figure 11, center panel) , the stimulation of autophosphorylation with respect to occupancy was shifted to the right and was almost rectilinear.
DISCUSSION
Peripheral resistance to hormone action has been recently recognized as an important pathogenic mechanism of endocrine diseases. In some syndromes, such as the syndrome of parathyroid hormone resistance (pseudohypoparathyroidism), specific molecular defects have been defined at the level of the guanidine-nucleotide regulatory protein that produce a subsequent defect in activation of adenylate cyclase. 3334 In the case of insulin, several genetic syndromes of extreme hormone resistance due to defects at the cellular level have also been recognized, including the type A syndrome of insulin resistance and acanthosis nigricans, 1~4 leprechaunism, 39 Among these, the type A syndrome of insulin resistance and acanthosis nigricans is the most striking. In most type A patients, endogenous insulin levels are increased 10-1,000 times above the normal levels and the patients often fail to respond to exogenous doses of insulin of 10,000 U of insulin/day or more. Although in all cases identified thus far there is little question about the cellular location of the defect, the molecular nature of the abnormality appears to be variable. The significance of the findings described in this report can be better understood in the context of recent advances in the structure and function of the insulin receptor.
Recent work by our laboratory and others has indicated that the insulin receptor is a glycoprotein that has the ability to bind specifically insulin and also possesses an insulinstimulated enzymatic activity. These two functions of the receptor appear to be contained in two distinct subunits: the a-subunit of M r = 135,000, which contains an insulin binding site, and the fJ-subunit of M r = 95,000, which contains a tyrosine-specific protein kinase. Upon binding of the hormone to the receptor, the kinase is activated, resulting in the autophosphorylation of the p-subunit on tyrosine residues 910 and also in the increase of a phosphotransferase activity toward some exogenous substrates. 1314 Table 2 ).
shown that covalent modification of the receptor through phosphorylation at the autophosphorylation sites catalyzes the phosphotransferase activity toward exogenous substrates. 13 Thus, measurement of the autophosphorylation of the insulin receptor may be a useful probe for the overall functional state of the receptor.
Most of the studies performed in type A patients have focused on the ability of insulin to bind to its receptor. A series of studies (mainly performed on circulating monocytes) have provided evidence for the notion that a major loss of cellular insulin receptors may account for the impairment of insulin action at the cellular level.
14 However, some studies have identified patients with normal or near-normal insulin binding (referred to as type C patients or type A variants). In these cases, a defect located at the postreceptor level has been hypothesized. 561920 The recent finding of defects in receptor kinase activity even in the presence of normal insulin binding properties of the receptor suggested that, 1920 in some of these patients, there may be a receptor defect at a postbinding level either in the kinase itself or in the coupling between the kinase and insulin binding subunits. To further explore the role of the insulin receptor kinase in the pathophysiology of this insulin-resistant state, we have performed a detailed biochemical characterization of the insulin receptor from three type A patients. For this study, erythrocyte insulin receptors have been used, since we have previously shown 18 that it is possible to quantitatively measure' insulin binding and insulin-stimulated phosphorylation under identical conditions allowing a direct correlation between the phosphorylation reaction and the binding properties of the receptor.
In the type A patients whom we studied, we found that the insulin binding defect was heterogenous in nature. Two of these patients presented a significant decrease in insulin binding and in one patient the binding was normal. Using computer-assisted statistical curve-fitting analysis and statistical evaluation, it was clear that in those cases with a decreased binding, one patient exhibited a decrease in total receptor number whereas the other exhibited a decrease in binding due to a decrease in the affinity constant of the receptor. The fact that these defects were observed in solubilized receptor preparations suggests that the defects are intrinsic to the receptor. Although insulin binding on circulating erythrocytes varies as a function of the age of red blood cells, 4041 it seems unlikely that this major decrease in binding could be explained by the alterations in erythrocyte life span, since routine hematologic parameters in these patients were normal. Moreover, the altered insulin binding properties of the receptor expressed on circulating erythrocytes appear to be genetic in nature, since similar defects can be detected in studies of culture fibroblasts from these patients.
42~44
Patient A^ appears to exhibit the "classic" defect of the type A syndrome, i.e., a major loss in receptor number on target cells. Since the amount of receptor in the detergent extract, as indicated by the insulin binding study, was also decreased, it was not surprising that the amount of maximal phosphate incorporation into the receptor would be decreased. Indeed, we observed a 70% and 80% decrease in both basal and maximal phosphate incorporation, respectively, in the preparation from this patient, consistent with a 70% decrease in the total number of receptors. The remaining receptors appeared to have normal binding and phosphorylating properties, as demonstrated by a normal affinity constant for binding and by the coupling plot between the binding and activation of the enzyme. Fifty percent stimulation of phosphorylation occurred with 10% fractional occupancy of the receptor, similar to the finding in normals. This type of defect has been found very frequently in other type A patients (Grigorescu et al., manuscript in preparation, and ref. 45) .
The defect described in patient A 2 has not been previously observed in type A patients. Insulin binding performed on intact erythrocytes or solubilized fractions indicated that the decreased binding was due to a significant decrease in receptor affinity constant. Despite normal total receptor number, maximal receptor autophosphorylation was also decreased about 70%. The exact contribution of the altered receptor affinity in transmembrane signal transmission and activation of kinase activity of the receptor is not completely understood. As is shown by the coupling plot, activation of the enzyme was less efficient at every level of receptor occupancy. Fifty percent stimulation of phosphorylation appeared at 50% of the fractional occupancy of the receptor with an almost linear correlation between occupancy and phosphorylation. This alteration is strikingly different from that observed in the other two patients and represents a new, unique type of defect in receptor function located at the level of the coupling between binding and kinase subunits of the receptor. Of course, the fact that the maximal extent of autophosphorylation was markedly decreased even at high insulin concentration when all receptors were occupied indicates that the autophosphorylation defect cannot be entirely explained by the decrease in receptor affinity for insulin.
Patient A 3 represents a third type of molecular defect, i.e., one in which a defect in autophosphorylation of the insulin receptor occurs despite normal insulin binding. This finding suggests that isolated alterations in the enzyme activity can exist independent of possible alterations in the hormone binding properties. In an apparently similar patient, Grunberger et al. 20 recently reported that monocytes may also exhibit such a dissociated defect. However, in contrast to the patient described in their report, our patient also exhibits a similar defect in culture cells, 19 suggesting that there is a true genetic defect in the receptor. In our patient, insulin binding performed with monocytes was entirely normal, but with intact erythrocytes insulin binding was slightly decreased when compared with the simultaneous control and was at the margin of 95% tolerance limits when compared with a group of 10 controls. When the receptor was solubilized from the erythrocyte membrane, both the binding capacity and affinity constant were indistinguishable from the controls, suggesting that the minor affinity modification seen in intact erythrocytes may be a reflection of some alterations in the membrane rather than in the receptor itself. This is further supported by the fact that the receptor structure as determined by affinity labeling and SDS-PAGE under reduced and nonreduced conditions was normal. The decreased autophosphorylation in this case could be due to the decreased ability of an abnormal (3-subunit to serve as a substrate for phosphorylation or to its kinase activity. Studies with fibroblast insulin receptors from this patient suggested that the latter is the case, since kinase activity toward exogenous substrates is decreased in proportion to the decrease in autophosphorylation. 19 The fact that the autophosphorylation also acts as a catalyst for the phosphotransferase activity 13 suggests that both activities should change in parallel.
In summary, the ability of insulin to stimulate the autophosphorylation reaction of the erythrocyte insulin receptor has afforded us a unique opportunity to probe the functional status of the receptor in the type A syndrome of insuiin resistance as compared with controls. We find that the type A syndrome is characterized by a heterogeneity of binding defects, but in all cases that we studied there is a major defect in receptor phosphorylation. This represents the first detailed description of a biochemical defect other than insulin binding located at the level of the erythrocyte insulin receptor. The finding has important implications in the pathogenesis of insulin resistance in this syndrome as well as in our fundamental concept of insulin action. The study also gives a new insight into the utility of acutely sampled erythrocytes in the clinical investigation of human diabetic syndromes.
